Pharmaceutical formulations containing zolmitriptan

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4045 (2006.01) A61K 9/00 (2006.01) A61K 31/00 (2006.01) A61K 31/422 (2006.01) A61P 25/06 (2006.01) C07D 413/06 (2006.01)

Patent

CA 2392050

A pharmaceutical formulation of the 5HT1-agonist, zolmitriptan, for use in intranasal administration. The formulation is useful in treating migraine and related disorders.

L'invention concerne une formulation pharmaceutique de l'agoniste sérotoninergique 5HT1, le zolmitriptan, pour administration intranasale. La formulation est utile pour traiter la migraine et des troubles apparentés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical formulations containing zolmitriptan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations containing zolmitriptan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations containing zolmitriptan will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1848136

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.